anmelden
OMX Stockholm 30
3.146,13
PKT
+30,15
PKT
+0,97
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 26.04.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 25.04.16 | Volvo (B) buy | Citigroup Corp. | |
| 25.04.16 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 25.04.16 | Volvo (B) Hold | Société Générale Group S.A. (SG) | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) kaufen | Independent Research GmbH | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 22.04.16 | Ericsson (Telefon L.M.Ericsson) (B) market-perform | Bernstein Research | |
| 21.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Bernstein Research | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 21.04.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 21.04.16 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.16 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 21.04.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.04.16 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 19.04.16 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 18.04.16 | AstraZeneca buy | UBS AG | |
| 18.04.16 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 15.04.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 14.04.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 12.04.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.04.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.04.16 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 07.04.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 06.04.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 01.04.16 | Volvo (B) Equal-Weight | Morgan Stanley | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.03.16 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 29.03.16 | AstraZeneca buy | UBS AG | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 22.03.16 | AstraZeneca Hold | HSBC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.